Clinical trial
Immunomodulation Analysis on Peripheral Blood Mononuclear Cells of Radiation Therapy in Pediatric Malignant Brain Tumors
NCT04019470 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immunomodulation Analysis on Peripheral Blood Mononuclear Cells of Radiation Therapy in Pediatric Malignant Brain Tumors
- Lead sponsor
- Capital Medical University
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- February 1, 2019
- Completion date
- May 31, 2022
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
brain tumor, pediatric